2014 - Fellow, National Academy of Inventors
1997 - Member of the National Academy of Medicine (NAM)
Immunology, Bone marrow, Transplantation, Stem cell and Immune tolerance are her primary areas of study. Her Immunology research includes elements of Total body irradiation, Haematopoiesis and Hematopoietic stem cell transplantation. Her work deals with themes such as Endocrinology and T lymphocyte, Immune system, which intersect with Bone marrow.
Her Transplantation study combines topics from a wide range of disciplines, such as Myeloid, T cell, B cell and Chimera. Her research investigates the connection with Stem cell and areas like Stromal cell which intersect with concerns in Andrology and Graft-versus-host disease. Her Immune tolerance study combines topics in areas such as Human leukocyte antigen, Immunity and Kidney transplantation.
Suzanne T. Ildstad focuses on Immunology, Transplantation, Bone marrow, Stem cell and Haematopoiesis. Her study connects Total body irradiation and Immunology. Her research in Transplantation intersects with topics in Immunosuppression, Tolerance induction, Antigen and Chimera.
The various areas that Suzanne T. Ildstad examines in her Immunosuppression study include Tacrolimus, Surgery and Kidney transplantation. Suzanne T. Ildstad combines subjects such as T lymphocyte, Major histocompatibility complex and Ratón with her study of Bone marrow. The Stem cell study combines topics in areas such as Cancer research and Stromal cell.
Her primary areas of investigation include Immunology, Stem cell, Transplantation, Haematopoiesis and Tolerance induction. Her Immunology research is multidisciplinary, incorporating elements of Hematopoietic stem cell transplantation and Hematopoietic stem cell. Suzanne T. Ildstad focuses mostly in the field of Stem cell, narrowing it down to matters related to Kidney and, in some cases, Biomarker.
Her Transplantation research includes themes of Cancer research, Chemokine, Total body irradiation, Peripheral blood mononuclear cell and Bone marrow. Her study looks at the relationship between Bone marrow and topics such as Progenitor cell, which overlap with CXCR4. Her Haematopoiesis study combines topics from a wide range of disciplines, such as CD8, T-cell receptor, FOXP3 and Homing.
Her primary areas of study are Immunology, Transplantation, Tolerance induction, Stem cell and Hematopoietic stem cell. Her Immunology research is multidisciplinary, incorporating perspectives in Transplantation Conditioning and Hematopoietic stem cell transplantation. Her Hematopoietic stem cell transplantation research includes elements of Organ transplantation and Kidney transplantation.
Her work carried out in the field of Transplantation brings together such families of science as Acquired immune system, T cell, Reperfusion injury and Bone marrow. Suzanne T. Ildstad interconnects Immunosuppression and Vascularized Composite Allotransplantation in the investigation of issues within Tolerance induction. Particularly relevant to Haematopoiesis is her body of work in Stem cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
J I Mayordomo;T Zorina;W J Storkus;L Zitvogel.
Nature Medicine (1995)
Cell migration, chimerism, and graft acceptance
Thomas E. Starzl;Anthony J. Demetris;Noriko Murase;Suzanne Ildstad.
The Lancet (1992)
Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
Suzanne T. Ildstad;David H. Sachs.
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
Thomas E. Starzl;Anthony J. Demetris;Massimo Trucco;Noriko Murase.
Cells Expressing Early Cardiac Markers Reside in the Bone Marrow and Are Mobilized Into the Peripheral Blood After Myocardial Infarction
Magda Kucia;Buddhadeb Dawn;Greg Hunt;Yiru Guo.
Circulation Research (2004)
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.
Thomas E. Starzl;Anthony J. Demetris;Massimo Trucco;Adriana Zeevi.
Systemic chimerism in human female recipients of male livers.
T.E Starzl;H Ramos;A Zeevi;C Ricordi.
The Lancet (1992)
Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation
Joseph Leventhal;Michael Abecassis;Joshua Miller;Lorenzo Gallon.
Science Translational Medicine (2012)
Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells.
Christina L. Kaufman;Yolonda L. Colson;Sherry M. Wren;Simon Watkins.
CHIMERISM AFTER LIVER TRANSPLANTATION FOR TYPE IV GLYCOGEN STORAGE DISEASE AND TYPE 1 GAUCHER’S DISEASE
Thomas E. Starzl;Anthony J. Demetris;Massimo Trucco;Camillo Ricordi.
The New England Journal of Medicine (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: